Small bowel adenocarcinomas in celiac disease follow the CIM-MSI pathway

Oncology Reports

Volumn 24, Issue 6, 2010, Pages 1535-1539

  Bergmann, Frank ^a   Singh, Sandhya ^a   Michel, Sara ^a   Kahlert, Christoph ^a   Schirmacher, Peter ^a   Helmke, Burkhard ^b   Doeberitz, Magnus Von Knebel ^a   Kloor, Matthias ^a   Bläker, Hendrik ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b Elbe Kliniken   (Germany)

Author keywords

Cancer; Celiac disease; Epigenetics; Small intestine

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER RISK; CARCINOGENESIS; CELIAC DISEASE; CONTROLLED STUDY; CPG ISLAND; DISEASE ASSOCIATION; DNA METHYLATION; FEMALE; GENE; HUMAN; HUMAN TISSUE; MALE; MICROSATELLITE INSTABILITY; MLH1 GENE; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; SMALL INTESTINE CARCINOMA;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CELIAC DISEASE; COHORT STUDIES; CPG ISLANDS; DISEASE PROGRESSION; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTESTINAL MUCOSA; INTESTINAL NEOPLASMS; INTESTINE, SMALL; MALE; MICROSATELLITE INSTABILITY; MIDDLE AGED; NUCLEAR PROTEINS; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEINS;

EID: 78649410451     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or-00001015     Document Type: Article

References (32)

1. Green PHR, Stavropoulos SN, Panagi SG, Goldstein SL, Mcmahon DJ, Absan H and Neugut AI: Characteristics of adult celiac disease in the USA: results of a national survey. Am J Gastroenterol 96: 126-131, 2001. (Pubitemid 32104819)
2. Green PH and Cellier C: Celiac disease. N Engl J Med 357: 1731-1743, 2007.
3. Marsh MN: The morphology and immunopathology of the jejunal lesion in gluten sensitivity. Eur J Gastroenterol Hepatol 3: 163-168, 1991.
4. Oberhuber G, Granditsch G and Vogelsang H: The histopathology of coeliac disease: time for a standardized report scheme for pathologists. Eur J Gastroenterol Hepatol 11: 1185-1194, 1999.
5. Catassi C, Bearzi I and Holmes GK: Association of celiac disease and intestinal lymphomas and other cancers. Gastroenterology 128: S79-S86, 2005.
6. Swinson CM, Slavin G, Coles EC and Booth CC: Coeliac disease and malignancy. Lancet 1: 111-115, 1983.
7. Rampertab SD, Forde KA and Green PH: Small bowel neoplasia in coeliac disease. Gut 52: 1211-1214, 2003.
8. Askling J, Linet M, Gridley G, Halstensen TS, Ekström K and Ekbom A: Cancer incidence in a population-based cohort of individuals hospitalized with celiac disease or dermatitis herpetiformis. Gastroenterology 123: 1428-1435, 2002.
9. Howdle PD, Jalal PK, Holmes GK and Houlston RS: Primary small-bowel malignancy in the UK and its association with coeliac disease. QJM 96: 345-353, 2003.
10. Rewers M: Epidemiology of celiac disease: what are the prevalence, incidence, and progression of celiac disease? Gastroenterology 128: S47-S51, 2005.
11. Johnston SD and Watson RG: Small bowel lymphoma in unrecognized coeliac disease: a cause for concern? Eur J Gastroenterol Hepatol 12: 645-648, 2000.
12. Bariol C, Suter C, Cheong K, Ku SL, Meagher A, Hawkins N and Ward R: The relationship between hypomethylation and CpG island methylation in colorectal neoplasia. Am J Pathol 162: 1361-1371, 2003. (Pubitemid 36350680)
13. Jass JR: Classification of colorectal cancer based on correlation of clinical, morphological and molecular features. Histopathology 50: 113-130, 2007.
14. Waki T, Tamura G, Sato M and Motoyama T: Age-related methylation of tumor suppressor and tumor-related genes: an analysis of autopsy samples. Oncogene 22: 4128-4133, 2003.
15. Issa JP, Ahuja N, Toyota M, Bronner MP and Brentnall TA: Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res 61: 3573-3577, 2001. (Pubitemid 32694963)
16. Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH and Kim JS: Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am J Pathol 163: 1551-1556, 2003.
17. Michel S, Kloor M, Singh S, Gdynia G, Roth W, von Knebel Doeberitz M, Schirmacher P and Bläker H: Coding microsatellite instability analysis in microsatellite unstable small intestinal adenocarcinomas identifies MARCKS as a common target of inactivation. Mol Carcinog 49: 175-182, 2010.
18. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN and Srivastava S: National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58: 5248-5257, 1998.
19. Findeisen P, Kloor M, Merx S, Sutter C, Woerner SM, Dostmann N, Benner A, Dondog B, Pawlita M, Dippold W, Wagner R, Gebert J and von Knebel Doeberitz M: T25 repeat in the 3′ untranslated region of the CASP2 gene: a sensitive and specific marker for microsatellite instability in colorectal cancer. Cancer Res 65: 8072-8078, 2005.
20. Chan AO, Issa JP, Morris JS, Hamilton SR and Rashid A: Concordant CpG island methylation in hyperplastic polyposis. Am J Pathol 160: 529-536, 2002.
21. Esteller M, Hamilton SR, Burger PC, Baylin SB and Herman JG: Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59: 793-797, 1999.
22. Herman JG, Graff JR, Myöhänen S, Nelkin BD and Baylin SB: Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93: 9821-9826, 1996.
23. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR and Wu TT: Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 162: 815-822, 2003. (Pubitemid 36237490)
24. West J, Logan RF, Hill PG, Lloyd A, Lewis S, Hubbard R, Reader R, Holmes GK and Khaw KT: Seroprevalence, correlates, and characteristics of undetected celiac disease in England. Gut 52: 960-965, 2003.
25. Di Sabatino A and Corazza GR: Coeliac disease. Lancet 373: 1480-1493, 2009.
26. Silano M, Volta U, Vincenzi AD, Dessì M and Vincenzi MD; Collaborating Centers of the Italian Registry of the Complications of Coeliac Disease: Effect of a gluten-free diet on the risk of enteropathy-associated T-cell lymphoma in celiac disease. Dig Dis Sci 53: 972-976, 2008.
27. Kingham JG, Ramanaden D and Dawson A: Metachronous small-bowel adenocarcinoma in coeliac disease: gluten-free diet is not protective. Scand J Gastroenterol 33: 218-222, 1998.
28. Piton G, Cosnes J, Monnet E, Beaugerie L, Seksik P, Savoye G, Cadiot G, Flourie B, Capelle P, Marteau P, Lemann M, Colombel JF, Khouri E, Bonaz B and Carbonnel F: Risk factors associated with small bowel adenocarcinoma in Crohn's disease: a case-control study. Am J Gastroenterol 103: 1730-1736, 2008.
29. Lynch HT, Smyrk TC, Lynch PM, Lanspa SJ, Boman BM, Ens J, Lynch JF, Strayhorn P, Carmody T and Cristofaro G: Adenocarcinoma of the small bowel in Lynch syndrome II. Cancer 64: 2178-2183, 1989.
30. Fearnhead NS, Britton MP and Bodmer WF: The ABC of APC. Hum Mol Genet 10: 721-733, 2001.
31. Potter DD, Murray JA, Donohue JH, Burgart LJ, Nagorney DM, van Heerden JA, Plevak MF, Zinsmeister AR and Thibodeau SN: The role of defective mismatch repair in small bowel adenocarcinoma in celiac disease. Cancer Res 64: 7073-7077, 2004.
32. Diosdado B, Buffart TE, Watkins R, Carvalho B, Ylstra B, Tijssen M, Bolijn AS, Lewis F, Maude K, Verbeke C, Nagtegaal ID, Grabsch H, Mulder CJ, Quirke P, Howdle P and Meijer GA: High-resolution array comparative genomic hybridization in sporadic and celiac disease-related small bowel adenocarcinomas. Clin Cancer Res 16: 1391-1401, 2010.